Clinical Trial Update: Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States

View source ↗

Summary

A United States clinical trial evaluating Xeomin (incobotulinumtoxinA) for cervical dystonia or blepharospasm has completed, sponsored by Merz North America, In…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blepharospasm
• Cervical Dystonia

Drugs mentioned

• XEOMIN (INCOBOTULINUMTOXINA)

Snippet

Sponsor: Merz North America, Inc. | Conditions: Cervical Dystonia, Blepharospasm | Status: COMPLETED